IQ-AI (LSE:IQAI) Institutional Ownership : 0.15% (As of Apr. 17, 2025)

View and export this data going back to 1993. Start your Free Trial

What is IQ-AI Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IQ-AI's institutional ownership is 0.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IQ-AI's Insider Ownership is 7.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IQ-AI's Float Percentage Of Total Shares Outstanding is 0.00%.

IQ-AI Institutional Ownership Historical Data

The historical data trend for IQ-AI's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQ-AI Institutional Ownership Chart

IQ-AI Historical Data

The historical data trend for IQ-AI can be seen below:

	2017-03-31	2017-04-30	2017-05-31	2017-06-30	2017-07-31	2017-08-31	2017-09-30	2017-10-31	2017-11-30	2017-12-31
Institutional Ownership	0.32	0.32	0.32	0.17	0.15	0.15	0.15	0.15	0.15	0.15

IQ-AI Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

IQ-AI Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » IQ-AI Ltd (LSE:IQAI) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Forum 4, Grenville Street, P.O. Box 264, Channel Islands, Saint Helier, JEY, JE4 8TQ

Website

https://www.imagingbiometrics.com

IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies. Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.

IQ-AI Headlines

No Headlines